These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2329449)

  • 21. Control release of prostaglandin E2 from polylactic acid microcapsules, microparticles and modified microparticles.
    Zhou MX; Chang TM
    J Microencapsul; 1988; 5(1):27-36. PubMed ID: 3199299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
    Park SJ; Kim SH
    J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique.
    Mandal TK; Lopez-Anaya A; Onyebueke E; Shekleton M
    J Microencapsul; 1996; 13(3):257-67. PubMed ID: 8860682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microencapsulation of ketoprofen using w/o/w complex emulsion technique.
    El-Gibaly I; Safwat SM; Ahmed MO
    J Microencapsul; 1996; 13(1):67-87. PubMed ID: 8903786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of process variables on essential oil microcapsule properties by carbohydrate polymer-protein blends.
    Banerjee S; Chattopadhyay P; Ghosh A; Goyary D; Karmakar S; Veer V
    Carbohydr Polym; 2013 Apr; 93(2):691-7. PubMed ID: 23499113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
    Hsu YY; Hao T; Hedley ML
    J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solvent exchange method: a novel microencapsulation technique using dual microdispensers.
    Yeo Y; Chen AU; Basaran OA; Park K
    Pharm Res; 2004 Aug; 21(8):1419-27. PubMed ID: 15359577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending.
    Embleton JK; Tighe BJ
    J Microencapsul; 1993; 10(3):341-52. PubMed ID: 8377092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of quercetin-loaded polymethyl methacrylate microcapsules using a polyol-in-oil-in-polyol emulsion solvent evaporation method.
    Lee DH; Sim GS; Kim JH; Lee GS; Pyo HB; Lee BC
    J Pharm Pharmacol; 2007 Dec; 59(12):1611-20. PubMed ID: 18053322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
    Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
    Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoencapsulation of a crystalline drug.
    Layre AM; Gref R; Richard J; Requier D; Chacun H; Appel M; Domb AJ; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):323-7. PubMed ID: 15899561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.
    Brunner CT; Baran ET; Pinho ED; Reis RL; Neves NM
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):498-507. PubMed ID: 21376545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Encapsulating acetaminophen into poly(L-lactide) microcapsules by solvent-evaporation technique in an O/W emulsion.
    Lai MK; Tsiang RC
    J Microencapsul; 2004 May; 21(3):307-16. PubMed ID: 15204597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aqueous core microcapsules as potential long-acting release systems for hydrophilic drugs.
    Abuhamdan RM; Al-Anati BH; Al Thaher Y; Shraideh ZA; Alkawareek MY; Abulateefeh SR
    Int J Pharm; 2021 Sep; 606():120926. PubMed ID: 34303818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone).
    Huatan H; Collett JH; Attwood D
    J Microencapsul; 1995; 12(5):557-67. PubMed ID: 8544099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
    Yin J; Noda Y; Yotsuyanagi T
    Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of thermal treatment on the physical-mechanical and dissolution properties of tablets containing poly(DL-lactic acid).
    Omelczuk MO; McGinity JW
    Pharm Res; 1993 Apr; 10(4):542-8. PubMed ID: 8483836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation of biodegradable liquid core PLLA microcapsules and hollow PLLA microcapsules using microfluidics.
    Lensen D; van Breukelen K; Vriezema DM; van Hest JC
    Macromol Biosci; 2010 May; 10(5):475-80. PubMed ID: 20336699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.